blokes almost the entire team at KSX have jumped ship from Resmed.
why would they hop onto this minnow when I'm sure they were getting paid top $$$$$$
Resmed turns over billions per year. They perfected the market and the Resmed boys have come over to duplicate the same model.
I read in one announcement that the WHolter Service Revenue Model could generate 8.0 million tests per year.
This represents US$200-300 per test in revenue in end-user price terms with approximately half of this reaching the Company once distribution costs are taken into account
so 8 million test per year * $100(conservative) = $800 million revenue per year from this one product to KSX.
time will tell but management seem in a hurry.
regards
KSX Price at posting:
2.4¢ Sentiment: Buy Disclosure: Held